Rituximab use, immune reconstitution, and vaccination after ex-vivo CD34-selected myeloablative allogeneic hematopoietic cell transplantation (HCT) Meeting Abstract


Authors: Preston, E. V.; Malard, F.; Seier, K.; Cho, C.; Devlin, S. M.; Maloy, M.; Borrill, T.; Palazzo, M.; Smith, K.; Maslak, P.; van den Brink, M. R. M.; Shah, G. L.; Perales, M. A.
Abstract Title: Rituximab use, immune reconstitution, and vaccination after ex-vivo CD34-selected myeloablative allogeneic hematopoietic cell transplantation (HCT)
Meeting Title: 2018 BMT Tandem Meetings
Journal Title: Biology of Blood and Marrow Transplantation
Volume: 24
Issue: 3 Suppl. 1
Meeting Dates: 2018 Feb 21-25
Meeting Location: Salt Lake City, UT
ISSN: 1083-8791
Publisher: Elsevier Inc.  
Date Published: 2018-03-01
Start Page: S360
End Page: S361
Language: English
ACCESSION: WOS:000425476000525
PROVIDER: wos
DOI: 10.1016/j.bbmt.2017.12.437
Notes: Meeting Abstract: 522 -- Meeting date is incorrect in the original publication's table of contents -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Miguel-Angel Perales
    456 Perales
  2. Peter Maslak
    182 Maslak
  3. Molly Anna Maloy
    171 Maloy
  4. Katherine M Smith
    30 Smith
  5. Sean McCarthy Devlin
    353 Devlin
  6. Christina Cho
    51 Cho
  7. Gunjan Lalitchandra Shah
    116 Shah
  8. Taylor Wray Borrill
    13 Borrill
  9. Florent Malard
    5 Malard
  10. Kenneth Seier
    38 Seier